Antimicrobial, antitumor and in vivo cytotoxicity of actinomycetes inhabiting marine shellfish

World Journal of Microbiology and Biotechnology

Volumn 25, Issue 9, 2009, Pages 1547-1555

  El Shatoury, Sahar A ^a   El Shenawy, Nahla S ^a   Abd El Salam, Ibrahim M ^b  

^a SUEZ CANAL UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Antimicrobial; Antitumor; Donax trunculus; Kidney toxicity; Liver toxicity; Marine actinomycetes; Shellfish

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTI-TUMOR ACTIVITIES; ANTI-TUMORS; ANTIMICROBIAL; CLINICAL CULTURES; ENZYMATIC ACTIVITIES; IN-VIVO; INHIBITORY EFFECT; LIVER TOXICITY; MARINE ACTINOMYCETE; POTENTIAL SOURCES; SOLID TUMORS; TOTAL PROTEIN;

LIVER; METABOLITES; TOXICITY; TUMORS; UREA;

METABOLISM;

ACTINOBACTERIA; ACTINOBACTERIA (CLASS); DONAX TRUNCULUS; KITASATOSPORA; NOCARDIOIDES; STREPTOMYCES;

EID: 71349086444     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-009-0040-4     Document Type: Article

References (32)

1. Bartels H, Boehmer M (1971) Microdetermination of creatinine. Clin Chim Acta 32: 81-85. doi: 10. 1016/0009-8981(71)90467-0.
2. Bernan VS, Greenstein M, Maiese WM (1997) Marine microorganisms as a source of new natural products. Adv Appl Microbiol 43: 57-90. doi: 10. 1016/S0065-2164(08)70223-5.
3. Bishop LM, Fody PE, Schoe HL (2005) Clinical chemistry principles, procedures correlations, 5th edn. Lippincoh Williams and Wilkins, Philadelphia, pp 220-253.
4. Bull AT, Stach JE (2007) Marine actinobacteria: new opportunities for natural product search and discovery. Trends Microbiol 15: 491-499. doi: 10. 1016/j. tim. 2007. 10. 004.
5. Castillo UF, Strobel GA, Ford EJ, Hess WM, Porter H, Jensen JB, Albert H, Robison R, Condron MA, Teplow DB, Stevens D, Yaver D (2002) Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans. Microbiology 148: 2675-2685.
6. Corbett T, Valeriote F, Polin L, Panchapor C, Pugh S, White K, Lowichik N, Knight J, Bissery M, Wozniak A, LoRusso P, Biemat L, Polin D, Knight L, Biggar S, Looney D, Demchik L, Jones J, Jones L, Blair S, Palmer K, Essenmacher S, Lisow L, Matter K, Cavanaugh P, Rake J, Baker L (1990) Discovery of solid tumor active agents using a soft-agar-colony formation disk-diffusion-assay. In: Valeriote R, Corbett T, Baker L (eds) Cytotoxic anticancer drugs: models and concepts for drug discovery and development. Kluwer, Norwell, pp 35-87.
7. Da Rocha AB, Lopes RM, Schwartsmann G (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1: 364-369. doi: 10. 1016/S1471-4892(01)00063-7.
8. Demain A, Davies J (1999) Manual of industrial microbiology and biotechnology. ASM, Washington.
9. Egan S, Thomas T, Kjelleberg S (2008) Unlocking the diversity and biotechnological potential of marine surface associated microbial communities. Curr Opin Microbiol 11(3): 219-225. doi: 10. 1016/j. mib. 2008. 04. 001.
10. El-Shatoury S (2007) Incidence of actinomycetes and faecal microbial contaminants in edible bivalve from Suez Canal Region, Egypt. Egypt J Nat Toxins (4): 21-38. ISSN: 1687-2116.
11. Fenical W, Jensen PR (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2: 666-673. doi: 10. 1038/nchembio841.
12. Fishelson L, Bresler V, Manelis R, Zuk-Rimon Z, Dotan A, Hornung H, Yawetz A (1999) Toxicological aspects associated with the ecology of Donax trunculus (Bivalvia, Mollusca) in a polluted environment. Sci Total Environ 226(2-3): 121-131. doi: 10. 1016/S0048-9697(98)00378-7.
13. Holt J, Krieg N, Sneath P, James S, Williams S (1994) Bergey's manual of determinative bacteriology, 9th edn. Williams and Wilkins, Baltimore.
14. Kieser T, Bibb M, Puttner M, Chater K, Hopwood D (2000) Practical Streptomyces genetics. The John Innes Foundation, Norwich.
15. Kwon HC, Kauffman CA, Jensen PR, Fenical W (2006) Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus 'Marinispora'. J Am Chem Soc 128: 1622-1632. doi: 10. 1021/ja0558948.
16. Le Guyader F, Haugarreau L, Miossec L, Dubois E, Pommepuy M (2000) Three-year study to assess human enteric viruses in shellfish. Appl Environ Microbiol 66: 3241-3248. doi: 10. 1128/AEM. 66. 8. 3241-3248. 2000.
17. Leary D, Vierros M, Hamon G, Arico S, Monagle C (2009) Marine genetic resources: a review of scientific and commercial interest. Mar Policy 33(2): 183-194. doi: 10. 1016/j. marpol. 2008. 05. 010.
18. Lee RJ, Younger AD (2002) Developing microbiological risk assessment for shellfish purification. Int Biodeterior Biodegrad 50: 177-183. doi: 10. 1016/S0964-8305(02)00084-7.
19. Longford S, Tujula NA, Crocetti G, Holmes AJ, Holmström C, Kjelleberg S, Steinberg PD, Taylor MW (2007) Comparisons of diversityn of bacterial communities associated with three sessile marine eukaryotes. Aquat Microb Ecol 48: 217-229. doi: 10. 3354/ame048217.
20. McLimans WF, Davis EV, Glover FL, Rake GW (1957) The submerged culture of mammalian cells: the spinner culture. J Immunol 79: 428-433.
21. Moss DW, Henderson AR (1999) Clinical enzomology. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd edn. WB Saunders Company, Philadelphia, pp 617-721.
22. Palton CJ, Crouch SR (1977) Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Anal Chem 49: 464-469. doi: 10. 1021/ac50011a034.
23. Qianqun G, Jia L, Chengbin C, Tianjiao Z, Yuchun F, Hongbing L, Weiming Z (2004) Recent researches of bioactive metabolites in marine organisms-associated microorganisms. J Ocean Univ China 3(2): 150-156. doi: 10. 1007/s11802-004-0026-7.
24. Romanenko LA, Uchino M, Kalinovskaya NI, Mikhailov VV (2008) Isolation, phylogenetic analysis and screening of marine mollusc-associated bacteria for antimicrobial, hemolytic and surface activities. Microbiol Res 163(6): 633-644. doi: 10. 1016/j. micres. 2006. 10. 001.
25. Salas JA, Me'ndez C (2007) Engineering the glycosylation of natural products in actinomycetes. Trends Microbiol 15(5): 219-232. doi: 10. 1016/j. tim. 2007. 03. 004.
26. Schaal K (1985) Identification of clinically significant actinomycetes and related bacteria using chemical techniques. In: Goodfellow M, Minnikin DE (eds) Chemical methods in bacterial systematics. Academic Press, London, pp 359-381.
27. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anti-cancer drug screening. J Natl Cancer Inst 82: 1107-1112. doi: 10. 1093/jnci/82. 13. 1107.
28. Staneck J, Roberts G (1974) Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl Microbiol 28: 226-231.
29. Stryer L (1995) Biochemistry, 4th edn. WH Freeman and Company, New York, pp 607-610 (Chapter 24).
30. Valeriote F, Grieshaber CK, Media J, Pietraszkewicz H, Hoffmann J, Pan M, McLaughlin S (2002) Discovery and development of anticancer agents from plants. J Exp Ther Oncol 2: 228-236. doi: 10. 1046/j. 1359-4117. 2002. 01038. x.
31. Vozarova B, Stefan N, Lindsay SR, Saremi A, Pratley ER, Bogardus C, Tatarnni AP (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 1889-1895. doi: 10. 2337/diabetes. 51. 6. 1889.
32. Zheng Z, Zeng W, Huang Y, Yang Z, Li J, Cai H, Su W (2000) Detection of antitumor and antimicrobial activities in marine organism associated actinomycetes isolated from the Taiwan Strait, China. FEMS Microbiol Lett 188: 87-89. doi: 10. 1111/j. 1574-6968. 2000. tb09173. x.